Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

PREVYMIS

LETERMOVIR

Standard Dose
240MG/12ML (20MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview PREVYMIS is listed in Drugs@FDA under application 209940 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient LETERMOVIR Form and strength SOLUTION;INTRAVENOUS - 240MG/12ML (20MG/ML) Sponsor MERCK SHARP DOHME Submission history Latest submission status date: 2025-01-30 00:00:00.

Structured Monograph

Clinical summary

Approval overview PREVYMIS is listed in Drugs@FDA under application 209940 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient LETERMOVIR Form and strength SOLUTION;INTRAVENOUS - 240MG/12ML (20MG/ML) Sponsor MERCK SHARP DOHME Submission history Latest submission status date: 2025-01-30 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.